Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Palmero S, Leone M, Prati M, et al
Glycosylation of pramlintide: synthetic glycopeptides that display in vitro and in vivo activities as amylin receptor agonists
27 , 12811293.e1287 (2018)
Notably, our results on GABA align with several prior studies using optimized sequences such as MEGA-PRESS [25], suggesting that methodological sensitivity is unlikely to be the sole factor responsible for the non-significant findings
Diabetologia 47(3):357366 Werner U, Haschke G, Herling AW, Kramer W (2010) Pharmacological profile of lixisenatide: a new GLP-1 receptor agonist for the treatment of type 2 diabetes
For example, in a study of almost 17,000 people published in JAMA Ophthalmology in 2024, researchers found an increased risk of NAION among individuals prescribed semaglutide relative to those prescribed other medications to treat type-2 diabetes and obesity
US$ 29.92
US$ 23.63
US$ 21.41
